KC filmmaker sees pleasure as a prequel to dystopia hiding ‘In Plain Sight’; His brave new wake-up call

October 8, 2024  |  Taylor Wilmore

Thomas Rex’s new proof-of-concept film project envisions a near-future world where society is on the verge of totalitarian control, he said, describing a cautionary tale about being unknowingly controlled by a culture of escapism through pleasure and pharmaceuticals.  

“In Plain Sight” serves as a prelude to Aldous Huxley’s novel “Brave New World,” an acclaimed but frequently banned 1932 science fiction book that explores the concept of a dystopian society built on conformity. Rex crafted “In Plain Sight” as a short film, with a screenplay that could a later be adapted into a feature-length film if the project is well-received.

“I want people to think critically about what’s going on around them,” said Rex. “We’re all responsible for the world we live in, and that starts with having difficult conversations. If we keep ignoring what’s happening right in front of us, we could end up in a reality that looks a lot like ‘ Brave New World.’”

Rex, the director, producer, and writer of “In Plain Sight,” has been captivated by such themes since his time at Olathe Northwest High School.

“I’ve always been fascinated by dystopias,” the serial entrepreneur said. “But ‘Brave New World’ struck me differently. It’s not driven by fear like ‘1984’ or ‘Fahrenheit 451’; it’s driven by pleasure, by a society that believes it’s free when, in reality, they’re trapped by their own comfort.”

Click here to follow the project’s progress on Instagram.

Blissfully controlled

Unlike direct adaptations of Huxley’s novel, “In Plain Sight” takes viewers to the moments before dystopia fully takes hold.

The proof-of-concept film project centers around pharmaceutical scientist Henry Foster who begins to uncover the truth about a drug being developed — a drug that will eventually become the “soma,” the pleasure-inducing substance that keeps the citizens of “Brave New World” in a state of blissful conformity.

“It’s about one man seeing things he’s not supposed to see,” said Rex. “He starts to piece together how the pharmaceutical industry, driven by the government, is setting up a system that will ultimately take away people’s freedom, but they won’t even realize it because they’ll think they’re happy.”

While Rex’s film is set in the 1960s, he sees many parallels to today’s world, particularly with the rise of social media and instant gratification. 

“Our society now is more like Brave New World than we realize,” he said, “Social media has trained us to expect instant happiness and to show only the best parts of our lives. That’s how people become controlled — by the pursuit of constant pleasure, and ignoring the negative.”

Actors Stewart Johnson and Rixie Ray engage with filmmaker Thomas Rex during a table read session for “In Plain Sight”; photo courtesy of Thomas Rex

Fueling the vision

To make In Plain Sight a reality, Rex launched a fundraiser with a $20,000 goal toward the film’s overall $50,000 budget. The money is expected to be used for production costs, including equipment, set design, and post-production work. 

Thomas Rex laughs during a table read session for “In Plain Sight”; photo courtesy of Thomas Rex

The support so far has been encouraging, said Rex, but there’s still a long way to go.

It had raised $17,000 by Tuesday, the date the campaign was initially expected to wrap.

“We’ve had amazing feedback and contributions, and that’s given us the confidence to push forward. But we need more help from anyone who believes in art and storytelling,” he said. “This film won’t happen without community backing.”

Filming is planned in Kansas City using local actors. For those who contribute, exclusive perks are offered: ranging from social media shoutouts to behind-the-scenes access during production. 

Rex hopes “In Plain Sight” will prompt viewers to question the direction society is heading. With themes of corporate greed, government control, and the manipulation of pleasure, the film is intended as a wake-up call,” he said.

Tagged
Featured Business
    Featured Founder
      [adinserter block="4"]

      2024 Startups to Watch

        stats here

        Related Posts on Startland News

        LaunchKC, Techweek to welcome 10 tech firms to KC in style

        By Tommy Felts | May 11, 2015

        In roughly four months, Kansas City will welcome a crop of tech startups bolstered by thousands of dollars in funding and a rockstar arrival. Kansas City’s LaunchKC competition — which aims to attract 10 tech firms to relocate to KC with $50,000 grants — has partnered with national tech conference Techweek to offer the winners…

        New platform GUILDit offers art entrepreneurs visibility

        By Tommy Felts | May 11, 2015

        A new program called GUILDit to promote and support art entrepreneurship is coming to Kansas City. The program is a bi-monthly gathering where art entrepreneurs take the stage to give six-minute presentations followed by questions and answers in the hopes of crafting a stronger Kansas City art economy, and to further connections between local artists.…

        HEMP brings Apple co-founder to KC as featured speaker

        By Tommy Felts | May 8, 2015

        Steve Wozniak, co-founder of Apple, will be the keynote speaker at The Helzberg Entrepreneurial Mentoring Program’s 20th anniversary celebration. Wozniak’s experience shaping the computing industry and influential product design for Apple have produced him fame as one of technology’s key thought leaders. “As a successful entrepreneur, Steve Wozniak understands the importance a mentor can make…

        In time for Mother’s Day: Ovatemp wants to boost women’s fertility

        By Tommy Felts | May 8, 2015

        The arrival of Ana Mayer’s baby girl isn’t the only thing she’ll be thinking about this Mother’s Day. Mayer — who’s among the newest founders in the Techstars-led Sprint Mobile Health Accelerator in Kansas City — will also be mulling how to further develop Ovatemp, the Boston-based ovulation tech company she leads. Ovatemp offers women…